W Janni
About
W Janni is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research.
According to data from OpenAlex, W Janni has authored 63 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 16 papers in Pulmonary and Respiratory Medicine and 16 papers in Cancer Research. Recurrent topics in W Janni's work include Cancer Treatment and Pharmacology (13 papers), Breast Cancer Treatment Studies (13 papers) and Advanced Breast Cancer Therapies (10 papers). W Janni is often cited by papers focused on Cancer Treatment and Pharmacology (13 papers), Breast Cancer Treatment Studies (13 papers) and Advanced Breast Cancer Therapies (10 papers). W Janni collaborates with scholars based in Germany, United States and Austria. W Janni's co-authors include Brigitte Rack, H. Sommer, Franz Kainer, B Schießl, Ursula Peschers, Katharina Jundt, Stephan Braun, Christian Schindlbeck, Andreas Schneeweiß and Dunja Maria Baston-Büst and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.
In The Last Decade
W Janni
53 papers receiving 358 citations
Peers
W Janni
J Jueckstock Germany
Kayla Morrell United States
Fabinshy Thangarajah Germany
Dai Shimizu Japan
Mohammad K. Hararah United States
Giuseppe Scibilia Italy
Norio Shiraki Japan
F. Khomsi Switzerland
Mark Sugi United States
Suk Bong Koh South Korea
Citations per year, relative to W Janni W Janni (= 1×)
peers
J Jueckstock
Countries citing papers authored by W Janni
Since
Specialization
Citations
This map shows the geographic impact of W Janni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W Janni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W Janni more than expected).
Fields of papers citing papers by W Janni
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by W Janni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W Janni. The network helps show where W Janni may publish in the future.
Co-authorship network of co-authors of W Janni
This figure shows the co-authorship network connecting the top 25 collaborators of W Janni. A scholar is included among the top collaborators of W Janni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W Janni. W Janni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Janni, W, et al.. (2026). Feasibility of Laparoscopic Radical Colpectomy in Locally Advanced Vaginal Cancer: A Case Report and Literature Review. Journal of Clinical Medicine. 15(1). 385–385.
2.
Pfister, K., Thomas W. P. Friedl, Astrid Fink, et al.. (2024). The SURVIVE HERoes trial – a secondary adjuvant treatment intervention study with trastuzumab deruxtecan (Enhertu) in early breast cancer patients with HER2-positive/HER2-low tumors and molecular relapse. Geburtshilfe und Frauenheilkunde. 84(10). e198–e199.
3.
Leinert, Elena, Markus Uhl, W Janni, et al.. (2024). Evaluation der neoadjuvanten Chemotherapie bei frühem Mammakarzinom unter Einbeziehung des Carbon Footprints und Patientinnenlogistik. Geburtshilfe und Frauenheilkunde. 84(6). e52–e52.
4.
Tarantino, Paolo, Joyce O’Shaughnessy, W Janni, et al.. (2024). 245P Characteristics of real-world (RW) NATALEE and monarchE eligible populations: A US electronic health records (EHR) database analysis. Annals of Oncology. 35. S317–S318.
5.
Schmid, M., et al.. (2022). Sind die Gynäkologen/Innen „grün“ nur im OP? Aufruf zum Umweltschutz. Geburtshilfe und Frauenheilkunde. 82(10). e121–e121.
6.
Hortobágyi, G. N., Salomon M. Stemmer, H.A. Burris, et al.. (2021). LBA17 Overall survival (OS) results from the phase III MONALEESA-2 (ML-2) trial of postmenopausal patients (pts) with hormone receptor positive/human epidermal growth factor receptor 2 negative (HR+/HER2−) advanced breast cancer (ABC) treated with endocrine therapy (ET) ± ribociclib (RIB). Annals of Oncology. 32. S1290–S1291.
7.
Látó, Krisztián, Peter Widschwendter, Thomas W. P. Friedl, et al.. (2018). Hypotension due to spinal anesthesia influences fetal circulation in primary caesarean sections. Archives of Gynecology and Obstetrics. 297(3). 667–674.
8.
Trapp, Elisabeth, Brigitte Rack, M. Kupka, et al.. (2017). Anti-Müllerian hormone (AMH) levels in premenopausal breast cancer patients treated with taxane-based adjuvant chemotherapy – A translational research project of the SUCCESS A study. The Breast. 35. 130–135.
9.
Jueckstock, J, et al.. (2015). Adjuvant therapeutic decisions in elderly breast cancer patients: the role of chemotherapy in a retrospective analysis. Archives of Gynecology and Obstetrics. 292(5). 1101–1107.
10.
Schwentner, Lukas, Achim Wöckel, J. König, et al.. (2014). Assessing the impact of CMF-like/Anthracycline-based/Anthracycline-Taxane-based/dose-dense chemotherapy in dependency of positive axillary lymph nodes/hormone receptor-status/grading/T-stage on survival – A retrospective multi-centre cohort study of 3677 patients receiving adjuvant chemotherapy. European Journal of Cancer. 50(17). 2905–2915.
11.
Ewijk, Reyn van, Achim Wöckel, Katharina Hancke, et al.. (2014). Is guideline-adherent adjuvant treatment an equal alternative for patients aged >65 who cannot participate in adjuvant clinical breast cancer trials? A retrospective multi-center cohort study of 4,142 patients. Archives of Gynecology and Obstetrics. 291(3). 631–640.
12.
Janni, W & Brigitte Rack. (2011). Gestationsbedingte Trophoblasttumoren. Der Gynäkologe. 44(6). 463–475.
13.
Baston-Büst, Dunja Maria, et al.. (2010). In vitro Culture Does Not Alter the Expression of Vascular Endothelial Growth Factor and Its Receptors in Single Murine Preimplantation Embryos. Gynecologic and Obstetric Investigation. 71(1). 24–31.
14.
Braun, Stephan, Bjørn Naume, E. Mueller, et al.. (2009). Results of the randomized phase II trial of adjuvant anastrozole versus anastrozole plus fulvestrant in hormone-receptor-positive postmenopausal breast cancer patients with bone marrow micrometastasis (ABCSG trial 21).. Cancer Research. 69(2_Supplement). 4159–4159.
15.
Janni, W, et al.. (2006). Die Therapie gynäkologischer Malignome in der Schwangerschaft. Zentralblatt für Gynäkologie. 128(3). 129–134.
16.
Schindlbeck, Christian, W Janni, Brigitte Rack, et al.. (2005). Isolated tumor cells in the bone marrow (ITC-BM) of breast cancer patients before and after anthracyclin based therapy: influenced by the HER2- and Topoisomerase IIα-status of the primary tumor?. Journal of Cancer Research and Clinical Oncology. 131(8). 539–546.
17.
Hildebrandt, Bert, S. Hegewisch-Becker, Thoralf Kerner, et al.. (2004). Current status of radiant whole-body hyperthermia at temperatures >41.5°C and practical guidelines for the treatment of adults. The German ‘Interdisciplinary Working Group on Hyperthermia’. International Journal of Hyperthermia. 21(2). 169–183.
18.
Gerber, B., A. Krause, Eva‐Maria Lochmüller, W Janni, & K Friese. (2004). Juvenile Gigantomastie. Ein Fallbericht und Literaturübersicht. Zentralblatt für Gynäkologie. 126(3). 167–169.
19.
Sommer, H., et al.. (2001). Palliative Therapie bei metastasiertem Mammakarzinom mit Tamoxifen und hochdosiertem Octreotid (Somatostatin-Analog) - Ergebnisse einer multizentrischen Phase-III-Studie. Zentralblatt für Gynäkologie. 123(10). 557–561.
20.
Janni, W, et al.. (2001). Prospektiv randomisierte Studie zum Vergleich der Wirksamkeit und der Verträglichkeit verschiedener niedermolekularer Heparine bei Hochrisikopatienten. Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie. 126(1). 32–38.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by J Jueckstock Breakdown of academic impact, for papers by Kayla Morrell Breakdown of academic impact, for papers by Fabinshy Thangarajah Breakdown of academic impact, for papers by Dai Shimizu Breakdown of academic impact, for papers by Mohammad K. Hararah Breakdown of academic impact, for papers by Giuseppe Scibilia Breakdown of academic impact, for papers by Norio Shiraki Breakdown of academic impact, for papers by F. Khomsi Breakdown of academic impact, for papers by Mark Sugi Breakdown of academic impact, for papers by Suk Bong Koh